AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
7.18
+0.01 (0.14%)
Jul 28, 2026, 10:54 AM EDT - Market open
AtaiBeckley Revenue
AtaiBeckley had revenue of $954.00K in the quarter ending March 31, 2026, a decrease of -38.65%. This brings the company's revenue in the last twelve months to $3.49M, up 87.22% year-over-year. In the year 2025, AtaiBeckley had annual revenue of $4.09M with 1,227.60% growth.
Revenue (ttm)
$3.49M
Revenue Growth
+87.22%
P/S Ratio
762.08
Revenue / Employee
$35,232
Employees
99
Market Cap
2.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.09M | 3.78M | 1,227.60% |
| Dec 31, 2024 | 308.00K | -6.00K | -1.91% |
| Dec 31, 2023 | 314.00K | 81.00K | 34.76% |
| Dec 31, 2022 | 233.00K | -20.14M | -98.86% |
| Dec 31, 2021 | 20.38M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ultragenyx Pharmaceutical | 670.00M |
| Tarsus Pharmaceuticals | 535.08M |
| Beam Therapeutics | 164.01M |
| Nurix Therapeutics | 36.77M |
| uniQure | 18.09M |
| Immunome | 4.02M |
| Celldex Therapeutics | 865.00K |
ATAI News
- 8 days ago - AtaiBeckley downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 8 days ago - AtaiBeckley downgraded to Hold from Buy at Berenberg - TheFly
- 9 days ago - The market for psychedelic drugs to treat mental health conditions gets a big buy signal - CNBC
- 10 days ago - AtaiBeckley downgraded to Hold from Buy at TD Cowen - TheFly
- 11 days ago - Helus Pharma price target lowered to $45 from $48 at Guggenheim - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at Jefferies - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at JonesResearch - TheFly
- 11 days ago - AtaiBeckley downgraded to Hold from Buy at Canaccord - TheFly